首頁 > 市場調查報告書 > 製藥

DDS 疼痛

市場調查報告書

商品編碼

1498658

全球非鴉片類止痛貼市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Non-Opioid Pain Patches Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球非鴉片類止痛貼市場需求預計將從 2023 年的 5.0824 億美元達到近 7.4688 億美元的市場規模，2024-2032 年研究期間複合年成長率為 4.37%。

非鴉片類止痛貼片是一種經皮治療系統，旨在在不使用鴉片類藥物的情況下緩解疼痛。這些貼片通常含有緩解局部疼痛的活性成分，如利多卡因、辣椒素或 NSAID（非類固醇抗發炎藥）。它們用於治療各種類型的疼痛，包括慢性疼痛、神經性疼痛和手術後疼痛。將貼片直接貼在疼痛部位的皮膚上，使藥物隨著時間的推移而穩定地吸收。它提供了鴉片類藥物的更安全替代品，降低了與鴉片類藥物使用相關的成癮風險和副作用。

市場動態

人們對鴉片類止痛藥的副作用和成癮潛力的認知不斷提高，刺激了對非鴉片類藥物替代品的需求，導致止痛貼的使用量激增。這些貼片透過經皮給藥系統提供局部疼痛緩解，最大限度地減少與口服藥物相關的全身性副作用，同時有針對性地緩解特定區域的不適。貼片配方和遞送機制的技術進步提高了非鴉片類止痛貼片的功效和便利性，使其越來越受到醫療保健專業人員和患者的青睞。緩釋製劑、新型藥物組合和改進的黏合性能等創新有助於更好的疼痛管理結果和患者依從性。此外，人口老化的不斷擴大，加上關節炎、神經病變和肌肉骨骼疾病等慢性疼痛疾病的發病率不斷上升，刺激了市場對非鴉片類止痛貼片的需求，將其作為長期疼痛管理的安全有效的替代品。

此外，旨在遏制鴉片類藥物濫用和推廣非藥物疼痛管理策略的監管舉措鼓勵醫療保健提供者開出止痛貼等非鴉片類藥物替代品，進一步促進市場成長。此外，疼痛貼片的便利性和謹慎性使患者能夠靈活地進行疼痛緩解治療，而無需頻繁給藥或侵入性操作，從而提高他們的生活品質並促進疼痛症狀的自我管理。然而，高昂的成本和有限的保險覆蓋範圍可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球非鴉片類止痛貼片市場的每個細分市場進行了包容性評估。非鴉片類止痛貼產業的成長和趨勢為本研究提供了整體方法。

市場區隔

非鴉片類止痛貼市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按類型

利多卡因貼劑
雙氯芬酸貼劑
水楊酸甲酯貼片
辣椒素貼片
酮洛芬貼劑
其他

按配銷通路

醫院藥房
網路藥局
藥局
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲非鴉片類止痛貼片市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。非鴉片類止痛貼片市場的主要參與者包括輝瑞公司、Mylan NV、葛蘭素史克公司、艾爾建、久光製藥有限公司、德成製藥有限公司、Acorda Therapeutics Ltd.、Teikoku Seiyaku Co. Ltd. 。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：非鴉片類止痛貼片公司的競爭格局

非鴉片類止痛貼市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Pfizer Inc.

公司簡介
公司收入
產品
最近的發展

Mylan NV

公司簡介
公司收入
產品
最近的發展

GlaxoSmithKline Plc

公司簡介
公司收入
產品
最近的發展

Allergan

公司簡介
公司收入
產品
最近的發展

Hisamitsu Pharmaceutical Co. Inc.

公司簡介
公司收入
產品
最近的發展

Teh Seng Pharmaceutical Mfg. Co.

公司簡介
公司收入
產品
最近的發展

Acorda Therapeutics Ltd.

公司簡介
公司收入
產品
最近的發展

Teikoku Seiyaku Co. Ltd.

公司簡介
公司收入
產品
最近的發展

IBSA Institut Biochimque SA Inc

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114766

The global demand for Non-Opioid Pain Patches Market is presumed to reach the market size of nearly USD 746.88 Million by 2032 from USD 508.24 Million in 2023 with a CAGR of 4.37% under the study period 2024-2032.

Non-opioid pain patches are transdermal therapeutic systems designed to deliver pain relief without the use of opioids. These patches generally comprise active ingredients such as lidocaine, capsaicin, or NSAIDs (nonsteroidal anti-inflammatory drugs) that relieve localized pain. They are used to treat various types of pain, including chronic pain, neuropathic pain, and post-surgical pain. The patch is directly applied to the skin over the painful area, allowing the medication to be absorbed steadily over time. It offers a safer alternative to opioid medications, lowering the risk of addiction & side effects associated with opioid use.

MARKET DYNAMICS

Rising awareness about the adverse effects and addictive potential of opioid-based pain medications has spurred the demand for non-opioid alternatives, leading to a surge in the adoption of pain patches. These patches offer localized pain relief through transdermal drug delivery systems, minimizing systemic side effects associated with oral medications while providing targeted relief to specific areas of discomfort. Technological advancements in patch formulations and delivery mechanisms have enhanced the efficacy and convenience of non-opioid pain patches, making them increasingly preferred among healthcare professionals and patients. Innovations such as extended-release formulations, novel drug combinations, and improved adhesive properties contribute to better pain management outcomes and patient compliance. Moreover, the expanding aging population, together with the spurring incidence of chronic pain conditions such as arthritis, neuropathy, and musculoskeletal disorders, fuels market demand for non-opioid pain patches as a safe and effective alternative for long-term pain management.

Additionally, regulatory initiatives aimed at curbing opioid misuse and promoting non-pharmacological pain management strategies further bolster market growth by encouraging healthcare providers to prescribe non-opioid alternatives like pain patches. Furthermore, the convenience and discreet nature of pain patches offer patients the flexibility to administer pain relief therapy without frequent dosing or invasive procedures, enhancing their quality of life and promoting self-management of pain symptoms. However, high costs and limited insurance coverage may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Non-Opioid Pain Patches. The growth and trends of Non-Opioid Pain Patches industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Non-Opioid Pain Patches market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others

By Distribution Channel

Hospitals Pharmacies
Online Pharmacies
Drug Stores
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Non-Opioid Pain Patches market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Non-Opioid Pain Patches market include Pfizer Inc., Mylan N.V., GlaxoSmithKline Plc, Allergan, Hisamitsu Pharmaceutical Co. Inc., Teh Seng Pharmaceutical Mfg. Co., Acorda Therapeutics Ltd., Teikoku Seiyaku Co. Ltd., IBSA Institut Biochimque SA Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. NON-OPIOID PAIN PATCHES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL NON-OPIOID PAIN PATCHES MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Lidocaine Patches Historic and Forecast Sales By Regions
5.4. Diclofenac Patches Historic and Forecast Sales By Regions
5.5. Methyl Salicylate Patches Historic and Forecast Sales By Regions
5.6. Capsaicin Patches Historic and Forecast Sales By Regions
5.7. Ketoprofen Patches Historic and Forecast Sales By Regions
5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL NON-OPIOID PAIN PATCHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospitals Pharmacies Historic and Forecast Sales By Regions
6.4. Online Pharmacies Historic and Forecast Sales By Regions
6.5. Drug Stores Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL NON-OPIOID PAIN PATCHES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE NON-OPIOID PAIN PATCHES COMPANIES

8.1. Non-Opioid Pain Patches Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF NON-OPIOID PAIN PATCHES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Pfizer Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Mylan N.V.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. GlaxoSmithKline Plc
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Allergan
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Hisamitsu Pharmaceutical Co. Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Teh Seng Pharmaceutical Mfg. Co.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Acorda Therapeutics Ltd.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Teikoku Seiyaku Co. Ltd.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. IBSA Institut Biochimque SA Inc
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments